Read More Energy Industry News Galderma’s breakthrough drug Nemluvio gains rapid FDA approval for severe itch condition Galderma has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) approving Nemluvio (nemolizumab) for… byPallavi MadhirajuAugust 14, 2024